Sustained-release liquisolid compact tablets containing artemether–lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance

References

• GuerraCAHowesREPatilAPThe international limits and population at risk of Plasmodium vivax transmission in 2009PLoS Negl Trop Dis20104e77420689816
   PubMed Web of Science ®Google Scholar
• HaySIOkiroEAGethingPWEstimating the global clinical burden of Plasmodium falciparum malaria in 2007PLoS Med20107e100029020563310
   PubMed Web of Science ®Google Scholar
• NnamaniPOHansenSWindbergsMLehrCMDevelopment of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical applicationInt J Pharm201447720821725290810
   PubMed Web of Science ®Google Scholar
• NnamaniPOScolesGKrölSPreliminary characterization of N-trimethylchitosan as a nanocarrier for malaria vaccineJ Vector Borne Disease201148422423022297285
   PubMed Web of Science ®Google Scholar
• EgunsolaOOshikoyaKAComparative safety of artemetherlumefantrine and other artemisinin-based combinations in children: a systematic reviewMalar J20131238524175945
   PubMed Web of Science ®Google Scholar
• VarshosazJEskandariSTabakhianMProduction and optimization of valproic acid nanostructured lipid carriers by the taguchi designPharm Dev Technol201015899619552542
   PubMed Web of Science ®Google Scholar
• ThatipamulaRPPalemCRGannuRMudragadaSYamsaniMRFormulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriersDaru201119233222615636
   PubMed Web of Science ®Google Scholar
• KasongoKWJanschMMullerRHWalkerRBEvaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nano-structured lipid carriers (NLCs) for potential targeting to the brainJ Liposome Res20112124525421174528
   PubMed Web of Science ®Google Scholar
• MandawgadeSDSharmaSPathakSPatravaleVBDevelopment of SMEDDS using natural lipophile: application to β-artemether deliveryInt J Pharm200836217918318652886
   PubMed Web of Science ®Google Scholar
• VarshosazJEskandariSTabakhianMFreeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectantsCarbohyd Polym20128811571163
   Web of Science ®Google Scholar
• TeeranachaideekulVSoutoEBMüllerRHJunyaprasertVPhysico-chemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels)J Microencapsul20082511112018246489
   PubMed Web of Science ®Google Scholar
• YangBLinJChenYLiuYArtemether/hydroxypropyl-b-cyclodextrin host–guest system: characterization, phase-solubility and inclusion modeBioorg Med Chem2009176311631719665897
   PubMed Web of Science ®Google Scholar
• ParasharDAdityaNPMurthyRSRDevelopment of artemether and lumefantrine co-loaded nanostructured lipid carriers: physico-chemical characterization and in vivo antimalarial activityDrug Deliv20142311724758139
   PubMed Web of Science ®Google Scholar
• AdityaNPPatankarSMadhusudhanBMurthyRSSoutoEBArtemether loaded lipid nanoparticles produced by modified thin-film hydration: pharmacokinetics, toxicological and in vivo anti-malarial activityEur J Pharm Sci20104044845520493255
   PubMed Web of Science ®Google Scholar
• AgubataCONzekweITAttamaAAMueller-GoymannCCOnunkwoGCFormulation, characterization and anti-malarial activity of homolipid-based artemether microparticlesInt J Pharm201547820222225448583
   PubMed Web of Science ®Google Scholar
• LefèvreGThomsenMSClinical pharmacokinetics of artemether and lumefantrine (Riamet®)Clin Drug Invest199918467480
   Web of Science ®Google Scholar
• EzzetFMullRKarbwangJPopulation pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patientsBr J Clin Pharmacol19984665535619862244
   PubMed Web of Science ®Google Scholar
• HienTTDavisTMChoungLVComparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malariaAntimicrob Agents Chemother200448114234423915504846
   PubMed Web of Science ®Google Scholar
• VranikovaBGajdziokJLiquisolid systems and aspects influencing their research and developmentActa Pharm20136344746524451071
   PubMed Web of Science ®Google Scholar
• NagabandiVKRamaraoTJayaveeraKNLiquisolid compacts: a novel approach to enhance bioavailability of poorly soluble drugsInt J Pharm Biol Sci2011189102
   Google Scholar
• GonjariIDKarmarkarABHosmaniAHEvaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tabletsDig J Nanomater Bios20094651661
   Web of Science ®Google Scholar
• MahajanHSDhamneMRGattaniSGRasalADShaikhHTEnhanced dissolution rate of glipizide by a liquisolid techniqueInt J Pharm Sci Nanotech2011312051213
   Google Scholar
• NnamaniPOIbezimECAttamaAAAdikwuMUSurface modified solid lipid microparticles based on homolipids and softisan® 142: preliminary characterizationAsian Pac J Trop Med2010205210
   Web of Science ®Google Scholar
• The British PharmacopeiaLondonHer Majesty’s Stationery office2004 Available from: https://www.pharmacopoeia.com/Accessed June 10, 2006
   Google Scholar
• AttamaAAOnuguCONnamaniPOAdikwuMNzekweITThe use of self-emulsifying systems in the delivery of diclofenacInt J Pharm2003262232812927384
   PubMed Web of Science ®Google Scholar
• RyleyJFPetersWThe antimalarial activity of some quinolone estersAnn Trop Med Parasitol197084209222
   Google Scholar
• AttamaAAMüller-GoymannCCA critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oilInt J Pharm2006322677816828247
   PubMed Web of Science ®Google Scholar
• MullerRHRadtkeMWissingSASolid lipid nanoparticles (SLN) nanostructured lipid carriers (NLC) in cosmetics and dermatological preparationsAdv Drug Deliv Rev200254S131S15512460720
   PubMed Web of Science ®Google Scholar
• Indian PharmacopeiaThe India Pharmacopoeia Commission Ghaziabad2007 Available from: http://www.ipc.gov.inAccessed June 19, 2010
   Google Scholar
• United States PharmacopeiaIn vitro and in vivo evaluation of dosage forms 200827th EdRevision, Easton, PA, USAMack Publishing Co.
   Google Scholar
• PintoMFMouraCCNunesCSegundoMACosta LimaSAReisSA new topical formulation for psoriasis: development of methotrexate-loaded nanostructures lipid carriersInt J Pharm201447751952625445970
   PubMed Web of Science ®Google Scholar
• HumphreysGSMerinopoulosIAhmedJWhittyCJMutabingwaTKSutherlandCJHallettRLAmodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malariaAntimicrob Agents Chemother20075199199717194834
   PubMed Web of Science ®Google Scholar
• KrugliakMDeharoEShalmievGSauvainMMorettiCGinsburgHAntimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivoExp Parasitol199581971057628573
   PubMed Web of Science ®Google Scholar
• KogaKKusawakeYSugiokaNShibataNEnhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfateEur J Pharm Biopharm200664829116750354
   PubMed Web of Science ®Google Scholar
• Rama PrasadYVEaimtrakarnSIshidaMEvaluation of oral formulations of gentamicin containing Labrasol in beagle dogsInt J Pharm2003268132114643972
   PubMed Web of Science ®Google Scholar
• ShaXYanGWuYLiJFangXEffect of self-microemulsifying drug delivery systems containing labrasol on tight junctions in Caco 2 cellsEur J Pharm Sci20052447748615784337
   PubMed Web of Science ®Google Scholar
• ChangRKShojaeiAHEffect of a lipoidic excipient on the absorption profile of compound UK 81252 in dogs after oral administrationJ Pharm Pharm Sci2004781215144729
   PubMed Web of Science ®Google Scholar